Does hypertension play a role in diabetic retinopathy?

Journal of Association of Physicians of India

Volumn 53, Issue SEPT., 2005, Pages 803-808

  Srivastava, B K ^a   Rema, M ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; DIABETIC RETINOPATHY; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INDIA; PATHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

COMORBIDITY; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INDIA; RISK ASSESSMENT; RISK FACTORS;

EID: 25444445057     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabetes Care 1998;21:143-56.
2. Rema M, Ponnaiya M, Mohan V. Prevalence of retinopathy in non-insulin dependent diabetes mellitus at a diabetes centre in southern India. Diab Res Clin Practice 1996;34:29-36.
3. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-26.
4. Rema M, Shanthirani CS, Deepa R, Mohan V. Prevalence of retinopathy in a selected south Indian population in the Chennai Urban population study (CUPS). Diab Res Clin Practice 2000;50(suppl1):1049.
5. Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study (UKPDS 30). Diabetic retinopathy at diagnosis of non-insulin dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998;116:297-303.
6. Rema M, Deepa R, Mohan V. Prevalence of retinopathy at diagnosis among Type 2 diabetic patients attending a diabetic centre in South India. Br J Ophthalmol 2000;84:1058-60.
7. Porta M, Bandello F. Diabetic retinopathy - a clinical update. Diabetologia 2002;45:1617-34.
8. Fredrick L, Ferris III, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Eng J Med 1999;26:667-78.
9. Wilkinson CP, Frederick LF, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular oedema disease severity scales. Ophthalmology 2003;110:1677-82.
10. Deepa R, Shanthirani CS, Pradeepa R, Mohan V. Is the "Rule of Halves" in hypertension still valid? - Evidence from the Chennai urban Population Study (CUPS). J Assoc Phys India 2003;51:153-57.
11. Gillow JT, Gibson JM, Dodson PM. Hypertension and diabetic retinopathy - What is the story? Br J Ophthalmol 1999;83:1083-87.
12. Klein R, Klein BEK. Blood pressure control and diabetic retinopathy. Br J Ophthal 2002;86:365-67.
13. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic study of diabetic retinopathy : XVII : The 14 year incidence and progression of diabetic retinopathy and associated risk factor in Type 1 diabetes. Ophthalmology 1998;105:1801-15.
14. Kohner EM, Patel V, Rassam SMB. Role of blood flow and impaired auto-regulation in the pathogenesis of diabetic retinopathy. Diabetes 1995;44:603-7.
15. Grunwald JE, Dupont J, Riva CE. Retinal haemodynamics in patients with early diabetes mellitus. Br J Ophthalmol 1996;80:327-31.
16. Findi O, Dallinger S, Rami B, et al. Ocular haemodynamics and colour contrast sensitivity in patients with Type 1 diabetes. Br J Ophthalmol 2000;84:493-98.
17. Rubia GDL, Oliver FJ, Inoguchi T, King GL. Induction of resistance to endothelin-1's biochemical actions by elevated glucose levels in retinal pericytes. Diabetes 1992;41:1533-39.
18. Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 1995;44:721-26.
19. Kastrup J, Norgaard T, Parving HH, Henriksen O, Lassen NA. Impaired autoregulation of blood flow in subcutaneous tissue of long term Type 1 (insulin dependent) diabetic patients with microangiopathy an index of arteriolar dysfunction. Diabetologia 1985;28:711-17.
20. Fuchsjager Mayrl G, Polak K, Luksch A, et al. Retinal blood flow and systemic blood pressure in healthy young subjects. Arch Clin Exp Ophthalmol 2001;239:673-77.
21. Jaap AJ, Shore AC, Gartside IB, Gamble J, Tooke JE. Increased microvascular fluid permeability in young Type 1 (insulin dependent) diabetic patients. Diabetologia 1993;36:648-52.
22. Schlingerman RO, Hinsbergh VWM. Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 1997;81:501-2.
23. Way KJ, Katai N, King GL. Protein kinase C and the development of diabetic vascular complications. Diabetic Medicine 2001;18:945-59.
24. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998;82:619-28.
25. Suzuma I, Hata Y, Clermont A, et al. Cyclic stretch and hypetension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2, potential mechanisms for exacerbation of diabetic retinopathy by hypertension. Diabetes 2001;50:444-54.
26. Balasubramanyam M, Rema M, Premanand C. Biochemical and molecular mechanisms of diabetic retinopathy. Current Science 2002;83:1506-14.
27. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
28. UK Prospective Diabetes Study (UKPDS) group : Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
29. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS 50 : Risk factor for incidence and progression of retinopathy in Type 2 diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-63.
30. Aiello LP, Cahill MT, Wong JS. Systemic considerations in the management of diabetic retinopathy. Am J Ophthalmol 2001;132:760-76.
31. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. The natural course of microalbuminuria in insulin dependent diabetes : A 10 year prospective study. Diab Med 1995;12:482-87.
32. American Diabetes Association. Detection and management of lipid disorders in diabetes. Diabetes Care 1993;16:828-38.
33. Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. Early treatment diabetic retinopathy study (ETDRS) Report 22. Arch Ophthalmol 1996;114:1079-84.
34. Sinclair SH, Del Vecchio C, Levin A. Treatment of anaemia in the diabetic patient with retinopathy and kidney disease. Am J Ophthalmol 2003;135:740-43.
35. UK Prospective Diabetes Study group : Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. Br Med J 1998;317:703-13.
36. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(suppl2):B54-B64.
37. Schrier RW, Estario RO, Jeffers B. Appropriate blood pressure control in NIDDM (ABCD) Trial. Diabetologia 1996;39:1646-54.
38. Hansson L, Zanchetti A, Carruthers SG. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension : principal results of the hypertension optimal treatment (HOT) randomized trial. The Lancet 1998;351:1755-62.
39. Adler A, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36) : Prospective Observational Study. Br Med J 2000;321:412-19.
40. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care 2003;26:S80-S82.
41. Chaturvedi N, Sjolie AK, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998;351:28-31.
42. UK Prospective Diabetes Study Group : Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 39. Br Med J 1998;317:713-20.